文献速递重症综合管理与镇静镇痛

机械通气期间药物诱导的深度镇静和情绪困扰与丧失独立生活能力的关联:一项观察性队列研究

Association of medication-induced deep sedation and emotional distress during mechanical ventilation with loss of independent living: an observational cohort study.
PubMed 文献 · Lancet Respir Med · 2025-10-11
一句话结论在ICU机械通气的成人中,药物诱导深度镇静时间比例与丧失独立生活能力独立相关,较轻镇静并允许识别情绪困扰和患者活动与较低风险相关。

该回顾性队列研究纳入2016年1月30日至2023年7月11日期间在纽约布朗克斯学术健康系统20个ICU中接受有创机械通气至少24小时且入院前独立生活的成人患者10204例。主要暴露为ICU入院第一周内药物诱导深度镇静(RASS -3至-5)的时间比例,次要暴露为情绪困扰指标的时间比例。主要结局为丧失独立生活能力(院内死亡或出院转长期专业护理机构),发生6369例(62.4%)。高比例药物诱导深度镇静与丧失独立生活能力风险增加相关(校正RR 1.18,95%CI 1.13-1.23,p<0.0001),高比例情绪困扰与风险降低相关(校正RR 0.88,95%CI 0.84-0.92,p<0.0001)。机械通气期间无患者活动与丧失独立生活能力相关(校正RR 1.32,95%CI 1.28-1.36,p<0.0001),并介导了深度镇静效应的32.5%(p<0.0001)。

要点

  • 在10204例机械通气成人中,高比例药物诱导深度镇静与丧失独立生活能力风险增加相关(校正RR 1.18,95%CI 1.13-1.23,p<0.0001)。
  • 高比例情绪困扰与丧失独立生活能力风险降低相关(校正RR 0.88,95%CI 0.84-0.92,p<0.0001),临床医生在情绪困扰时和夜间给予更深镇静(两项比较p<0.0001)。
  • 使用抗精神病药或非阿片类镇痛药控制症状与丧失独立生活能力风险降低相关(校正RR 0.95,95%CI 0.91-0.99,p=0.013)。
  • 机械通气期间无患者活动与丧失独立生活能力相关(校正RR 1.32,95%CI 1.28-1.36,p<0.0001),并介导深度镇静效应的32.5%(p<0.0001)。
  • 作者认为,较轻镇静、允许识别情绪困扰和患者活动与较低的丧失独立生活能力风险相关。

适用人群与场景

  • 成人患者(年龄≥18岁),入院前独立生活,在学术健康系统20个ICU中接受有创机械通气至少24小时。
  • 研究地点为纽约布朗克斯(美国纽约州)及相邻县的学术健康系统。

诊断标准与关键阈值

  • 药物诱导深度镇静定义为Richmond躁动镇静评分(RASS)-3至-5。
  • 暴露按ICU入院第一周内时间比例分为无、低比例和高比例,以中位数作为低与高的切点:药物诱导深度镇静42.9%,情绪困扰10.7%。
  • 主要结局丧失独立生活能力定义为院内死亡或术后出院转长期专业护理机构。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入10204例接受有创机械通气的成人患者,来自20个ICU。
  • 6369例(62.4%)发生丧失独立生活能力。
  • 7289例(71.4%)患者在ICU机械通气第一周内至少有一次药物诱导深度镇静发作。
  • 接受深度镇静的患者比例平均为有深度镇静医嘱的患者比例的2.84倍(标准差1.51)。
  • 与无药物诱导深度镇静相比,高比例药物诱导深度镇静与丧失独立生活能力风险增加相关(校正RR 1.18,95%CI 1.13-1.23,p<0.0001)。
  • 共记录30022次情绪困扰发作;与无情绪困扰相比,高比例情绪困扰与丧失独立生活能力风险降低相关(校正RR 0.88,95%CI 0.84-0.92,p<0.0001)。
  • 临床医生在情绪困扰时和夜间给予更深镇静(两项比较p<0.0001)。
  • 与无治疗相比,使用抗精神病药或非阿片类镇痛药控制症状与丧失独立生活能力风险降低相关(校正RR 0.95,95%CI 0.91-0.99,p=0.013)。

证据类型、等级与局限

  • 证据类型为回顾性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,较轻镇静、允许识别情绪困扰和患者活动与较低的丧失独立生活能力风险相关。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Deep sedation can be used during invasive mechanical ventilation without proven indication to treat the signs and symptoms of emotional distress or insomnia. However, medication-induced deep sedation is associated with delayed recovery and increased mortality. We tested the hypothesis that medication-induced deep sedation, but not emotional distress, is associated with loss of independent living.

METHODS: In this retrospective cohort study, we included adult patients (age ≥18 years) who lived independently before hospital admission and were mechanically ventilated for at least 24 h in any of 20 ICUs at an academic health system in the Bronx, New York (NY, USA), and adjacent counties. The primary exposure was the proportion of time spent in medication-induced deep sedation (defined as a Richmond Agitation Sedation Score of -3 to -5) within the first week of ICU admission. The secondary exposure was the proportion of time with indicators of emotional distress within the first week of ICU admission. The exposures were categorised as none, a low proportion, or a high proportion using the median (42·9% for medication-induced deep sedation and 10·7% for emotional distress) as the cutoff between low and high. The primary outcome was loss of independent living (defined as in-hospital death or postoperative discharge to a long-term skilled nursing facility). Modified Poisson regression with an a priori-defined confounder control model were used to assess the association between exposures and outcomes. Mediation analysis was done to evaluate whether patient mobilisation level during mechanical ventilation contributed to the association between deep sedation and loss of independent living.

FINDINGS: Among 10 204 patients receiving invasive mechanical ventilation between Jan 30, 2016 and July 11, 2023, 6369 (62·4%) had a loss of independent living. The proportion of patients who received deep sedation was a mean 2·84-fold (SD 1·51) higher than the proportion of patients who had an order for deep sedation. 7289 (71·4%) patients had at least one episode of medication-induced deep sedation within the first week of mechanical ventilation in the ICU. A high proportion of medication-induced deep sedation was associated with an increased risk of loss of independent living (adjusted risk ratio [RRadj] 1·18 [95% CI 1·13-1·23], p<0·0001) compared with no medication-induced deep sedation. There were 30 022 documented episodes of emotional distress. Having a high proportion of emotional distress was associated with a decreased risk of loss of independent living (RRadj 0·88 [0·84-0·92], p<0·0001) compared with no emotional distress. Clinicians provided deeper sedation in response to emotional distress and during the night (p<0·0001 for both comparisons). Symptom control with antipsychotics or non-opioid analgesics was associated with a decreased risk of loss of independent living compared with no treatment (RRadj 0·95 [0·91-0·99], p=0·013). Absence of patient mobility during mechanical ventilation was associated with loss of independent living (RRadj 1·32 [1·28-1·36], p<0·0001) and mediated 32·5% (p<0·0001) of the effects of deep sedation on loss of independent living.

INTERPRETATION: Among mechanically ventilated adults in an ICU, the proportion of time spent in medication-induced deep sedation was independently associated with loss of independent living. Lighter sedation, allowing for recognition of emotional distress and for patient mobility, was associated with a lower risk of loss of independent living.

FUNDING: Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine (New York, NY, USA).

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Wongtangman K, Borngaesser F, Rudolph MI, et al. Association of medication-induced deep sedation and emotional distress during mechanical ventilation with loss of independent living: an observational cohort study. Lancet Respir Med. 2025. PMID: 41086817. doi:10.1016/S2213-2600(25)00264-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。